SCHEMBL3235252

SCHEMBL3235252

CCOc1ccc2c(c1)C(C)(c1cccc(OCCCN(C)C)c1)C(=O)N2S(=O)(=O)c1ccc(C(=O)NC(C)(C)C)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AVPR1A P37288 1/20 0.41
CACNA1B Q00975 3/20 0.39
RECQL P46063 2/20 0.38
MAPT P10636 1/20 0.38
LMNA P02545 2/20 0.38
ROCK2 O75116 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
ROCK1 Q13464 1/20 0.37
KMT2A Q03164 3/20 0.37
MEN1 O00255 2/20 0.37
UBE2N P61088 1/20 0.36
ALDH1A1 P00352 2/20 0.35
HSP90B1 P14625 1/20 0.34
TRAP1 Q12931 1/20 0.34
CACNA1H O95180 1/20 0.34
PAX8 Q06710 1/20 0.34
HTT P42858 1/20 0.34
KDM4E B2RXH2 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3225219 0.92 AVPR1A (0.43) AVPR1ARECQLMAPTLMNAKMT2A
SCHEMBL3229236 0.87 AVPR1A (0.43) AVPR1ARECQLMAPTLMNACYP2C9
SCHEMBL3234537 0.87 AVPR1A (0.45) AVPR1ARECQLMAPTLMNACYP2C9
SCHEMBL3237015 0.81 AVPR1A (0.40) AVPR1ARECQLMAPTLMNACYP2C9
SCHEMBL3236849 0.81 AVPR1A (0.45) AVPR1ARECQLMAPTLMNACYP2C9
SCHEMBL3235051 0.81 AVPR1A (0.43) AVPR1ARECQLMAPTLMNACYP2C9
SCHEMBL3233628 0.81 AVPR1A (0.43) AVPR1ARECQLMAPTLMNACYP2C9
SCHEMBL3226251 0.81 AVPR1A (0.43) AVPR1ARECQLMAPTLMNAKMT2A
SCHEMBL3228428 0.78 AVPR1A (0.43) AVPR1ARECQLMAPTLMNACYP2C9
SCHEMBL3226354 0.77 AVPR1A (0.42) AVPR1ARECQLMAPTLMNACYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2097374-B1 5-ALKYLOXY-INDOLIN-2-ONE DERIVATIVES, PREPARATION THEREOF AND APPLICATION THEREOF IN THERAPY AS SELECTIVE LIGANDS OF V2 VASOPRESSIN RECEPTORS SANOFI AVENTIS (FR) 2010-06-09 EP disclosed
US-20100069384-A1 5-ALKYLOXY-INDOLIN-2-ONE DERIVATIVES, PREPARATION THEREOF AND APPLICATION THEREOF IN THERAPY SANOFI-AVENTIS (FR) 2010-03-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100069384-A1 5-ALKYLOXY-INDOLIN-2-ONE DERIVATIVES, PREPARATION THEREOF AND APPLICATION THEREOF IN THERAPY AVPR2, AVPR1A, AVPR1B AVPR1A 2/4885CACNA1B 802/4885RECQL 3615/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.